Cancer
USC and Tempus Join Forces in Strategic Partnership to Accelerate Innovation in Research and Patient Care
The Keck School of Medicine of USC, in partnership with Keck Medicine of USC, has initiated a groundbreaking collaboration with...
Decoding the Progression of Leukemia in Children with Down Syndrome
Groundbreaking research has unveiled new molecular insights that could revolutionize the way we predict and potentially treat a rare form...
Rectal Cancer Emerging Sooner and Progressing More Aggressively, Study Finds
In recent years, colorectal cancer has undergone a troubling epidemiological shift, particularly affecting younger adults who were historically considered low...
CDKN1B Loss Fuels ER Therapy Resistance in Breast Cancer
In the evolving landscape of breast cancer treatment, hormone receptor-positive (HR+), HER2-negative breast cancer has long presented both opportunities and...
Breakthrough Discovery: Young Microbiome Holds Key to a Healthy Liver
In a groundbreaking study poised to reshape our understanding of aging and cancer biology, researchers have unveiled compelling evidence that...
Icaritin Reverses STAT3-Driven EGFR-TKI Resistance
In the relentless battle against non-small cell lung cancer (NSCLC), targeted treatments such as epidermal growth factor receptor tyrosine kinase...
Postmenopausal Ovarian Cancer Case Mistaken for Pelvic Abscess, Leading to Diagnostic Delay
In a compelling new case report published in the March 2026 issue of Oncoscience, researchers present a diagnostically perplexing manifestation...
AACR 2026 Research Roundup: Cutting-Edge Cancer Discoveries from MSK
At the forefront of cancer innovation, researchers from Memorial Sloan Kettering Cancer Center (MSK) showcased groundbreaking advancements at the 2026...
Enhancer Identified as Promising Target for Tackling ‘Undruggable’ MYC in Pediatric Medulloblastoma
In a groundbreaking study published in the prestigious journal Cancer Research on April 22, 2026, researchers at St. Jude Children’s...
Wayne State University and Barbara Ann Karmanos Cancer Institute Launch Digital Engagement and Cancer Outcomes Center Funded by ACS Grant
Wayne State University and the Barbara Ann Karmanos Cancer Institute have launched a pioneering initiative to tackle cancer disparities exacerbated...
Experimental Breast Cancer Drug Floods Tumors with a “Surge” of Toxic Lipids
A novel experimental drug known as DH20931 has emerged as a promising candidate in the battle against triple-negative breast cancer...
PET Biomarker Surpasses Traditional Risk Scores in Predicting Survival Outcomes for Large B-Cell Lymphoma Patients
In a groundbreaking advancement for the treatment of large B-cell lymphoma (LBCL), researchers have demonstrated that metabolic tumor volume (MTV),...
Midlife Fitness Tied to Increased Longevity and Better Health Outcomes
A groundbreaking study published in the Journal of the American College of Cardiology (JACC) has brought to light crucial insights...
Bioengineered Chewing Gum: A New Weapon Against Oral Cancer
A groundbreaking study spearheaded by Henry Daniell and his team at the University of Pennsylvania’s School of Dental Medicine has...
Childhood Sexual Abuse: A Long-Term Risk Factor for Cancer in Older Adults
New research from the University of Toronto and the University Health Network shines a piercing light on the enduring shadows...
Laparoscopic Glissonian vs. Hilar Dissection in Hepatectomy
In a landmark study published on April 22, 2026, researchers have shed significant light on a contentious surgical debate pivotal...
γδ T Cells: Key Players in Colorectal, Liver Cancer
Gamma delta (γδ) T cells represent an intriguing subset of the immune system that has garnered increasing attention for their...
Mayo Clinic Study Backs Targeted Therapy to Manage Kidney Side Effects, Helping Patients Continue Lifesaving Immunotherapy
Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by empowering the immune system to recognize and attack tumor cells. However,...
Unveiling Cancer’s Origins: How Mutated Cells Remodel Their Surroundings to Spark Tumor Growth
Researchers at Memorial Sloan Kettering Cancer Center have unveiled pivotal insights into the earliest stages of tumor formation in lung...
New Insights into Risk Factors and Biomarkers of Immune Checkpoint Inhibitor-Induced Hepatotoxicity: Emerging Trends and Future Directions
Immune checkpoint inhibitors (ICIs) have ushered in a new era in oncology, transforming the therapeutic landscape for a variety of...
